Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_assertion description "[In addition, this subtype of t-AML is characterized by a unique expression profile (higher expression of genes) involved in cell cycle control (CCNA2, CCNE2, CDC2), checkpoints (BUB1), or growth (MYC), loss of expression of IRF8, and overexpression of FHL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_assertion evidence source_evidence_literature NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_assertion SIO_000772 19958752 NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_assertion wasDerivedFrom befree-2016 NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_assertion wasGeneratedBy ECO_0000203 NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.
- befree-2016 importedOn "2016-02-19" NP779267.RAb1N-jlFPccIN6ZBD8q_yyP5SKx7e4fkCMEl31Tvm-NU130_provenance.